The 6 most recent market catalysts affecting $SCNX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 22, 2026
Corporate Catalyst
Bullish
Impact 75
Scienture Holdings Issues Shareholder Letter Highlighting Financial and Commercial Progress
Scienture Holdings released a shareholder letter highlighting substantial sequential revenue growth of 256% for the first nine months of the year. This significant financial improv…
Oct 13, 2026
Corporate Catalyst
Bullish
Impact 75
EXCLUSIVE: Scienture Revenue Soars 256% As Drugmaker Targets 2027 Profitability
Scienture Holdings Inc. (SCNX) announced preliminary third-quarter revenue of $1.22 million, a substantial 256% increase from the previous quarter. This growth is primarily attribu…
Oct 2, 2026
Corporate Catalyst
Bullish
Impact 65
EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions
Scienture Holdings (SCNX) secured formulary additions for its hypertension drug, Arbli, in three leading pediatric hospitals. This is a positive development as it expands the drug'…
Oct 1, 2026
Corporate Catalyst
Bearish
Impact 75
Scienture Holdings (SCNX) Stock Drops 19% After Hours: Here's What Happened
Scienture Holdings announced a 1-for-25 reverse stock split, a corporate action typically undertaken by companies whose stock price has fallen significantly. The primary stated rea…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 85
Scienture Holdings Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $343.639K Miss $1.964M Estimate
Scienture Holdings (SCNX) reported its Q2 earnings, showing a mixed performance. While the company managed to beat analyst estimates for earnings per share, reporting a loss of $(0…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 75
EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US
Scienture Holdings (SCNX) has announced the commercial rollout of Rezenopy, its 10mg naloxone nasal spray, which is the highest-dose product of its kind on the market. This is a si…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.